Avidin joined to fourth cystic fibrosis consortium (H2020 TAT-CF) progress meeting in Mallorca (Spain)

Day one was dedicated to the 3rd TAT-CF workshop in which researchers from all partners presented their work within the H2020 project (Novel therapeutic approaches for the treatment of cystic fibrosis based on small molecule transmembrane anion transporters No 667079).

The second day, principal investigators discussed key issues during the Steering Committee meeting. The project has entered into its last year of development, therefore crucial decisions were made in order to accomplish all the planned aims.

4th TAT-CF progress meeting in Mallorca (Spain)